Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 4
2006 2
2007 1
2008 1
2010 1
2011 1
2012 2
2013 5
2014 5
2015 2
2016 1
2017 2
2018 2
2019 2
2022 3
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Aspirin for primary prevention of CVD in CKD: where do we stand?
Gallagher H, Lown M, Fuat A, Roderick P. Gallagher H, et al. Among authors: fuat a. Br J Gen Pract. 2019 Nov 28;69(689):590-591. doi: 10.3399/bjgp19X706661. Print 2019 Dec. Br J Gen Pract. 2019. PMID: 31780468 Free PMC article. No abstract available.
A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care.
Charman SJ, Okwose NC, Stefanetti RJ, Bailey K, Skinner J, Ristic A, Seferovic PM, Scott M, Turley S, Fuat A, Mant J, Hobbs RFD, MacGowan GA, Jakovljevic DG. Charman SJ, et al. Among authors: fuat a. ESC Heart Fail. 2018 Aug;5(4):703-712. doi: 10.1002/ehf2.12302. Epub 2018 Jun 26. ESC Heart Fail. 2018. PMID: 29943902 Free PMC article.
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
Gallagher H, Dumbleton J, Maishman T, Whitehead A, Moore MV, Fuat A, Fitzmaurice D, Henderson RA, Lord J, Griffith KE, Stevens P, Taal MW, Stevenson D, Fraser SD, Lown M, Hawkey CJ, Roderick PJ. Gallagher H, et al. Among authors: fuat a. Trials. 2022 Apr 21;23(1):331. doi: 10.1186/s13063-022-06132-z. Trials. 2022. PMID: 35449015 Free PMC article.
35 results